Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
5 Patents
#12 in Lancashire
#3,216 in United Kingdom
Invibio Limited
Forward Citations = 30
7 inventors:
Invibio Limited
% Expired Patents = 80.0
EPO Patents = 5
Trademarks = 7
Forward Citations = 30
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Marcus Jarman-Smith (3 out of 3 patents)
Adam Briscoe (1 out of 3 patents)
Andrew Elleray (1 out of 2 patents)
4. Nuno Sereno (1 out of 1 patent)
5. Craig Valentine (1 out of 1 patent)
6. Vaughn Williams (1 out of 1 patent)
7. Andrew Holden (1 out of 1 patent)
8. John Neil Devine (4 patents)
9. Keith Cartwright (2 patents)
10. Tony Whitehead (0 patent)
11. Mark Brady (0 patent)
5 patents:
Company Overview
Invibio is a leading provider of biomaterial solutions used in medical implants and devices. The company specializes in PEEK-OPTIMA polymers, which offer superior mechanical, biocompatibility, and wear resistance properties. Invibio collaborates with medical professionals and device manufacturers to develop innovative solutions for various medical applications.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Invibio Limited. Retrieved from https://idiyas.com/company/invibio
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]